(1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane

C20H30O6 — CID 100942568

IUPAC(1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane
SMILESCOC[C@@H]1[C@H]([C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@H]3OC(C)(C)O[C@H]32)[C@@H]2C=C[C@H]1C2
InChIInChI=1S/C20H30O6/c1-19(2)23-15-14(13-11-7-6-10(8-11)12(13)9-21-5)22-18-17(16(15)24-19)25-20(3,4)26-18/h6-7,10-18H,8-9H2,1-5H3/t10-,11+,12-,13+,14+,15-,16-,17+,18+/m0/s1
InChIKeyHWMIOEAGGSYLQC-HSBSSMNMSA-N
MW366.45 g/mol
LogP2.47
Rot. Bonds3

About (1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane

(1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane (PubChem CID 100942568) has the molecular formula C20H30O6 and a molecular weight of 366.45 g/mol. Its IUPAC name is (1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane.

Molecular Properties

Compound Name(1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane
PubChem CID100942568
Molecular FormulaC20H30O6
Molecular Weight366.45 g/mol
Exact Mass366.20
IUPAC Name(1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane
SMILESCOC[C@@H]1[C@H]([C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@H]3OC(C)(C)O[C@H]32)[C@@H]2C=C[C@H]1C2
InChIInChI=1S/C20H30O6/c1-19(2)23-15-14(13-11-7-6-10(8-11)12(13)9-21-5)22-18-17(16(15)24-19)25-20(3,4)26-18/h6-7,10-18H,8-9H2,1-5H3/t10-,11+,12-,13+,14+,15-,16-,17+,18+/m0/s1
InChIKeyHWMIOEAGGSYLQC-HSBSSMNMSA-N
XLogP2.47
TPSA55.38 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500366.45
LogP ≤ 52.47
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane?
The IUPAC name of (1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane (CID 100942568) is (1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane.
What is the SMILES notation for (1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane?
The canonical SMILES for (1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane is COC[C@@H]1[C@H]([C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@H]3OC(C)(C)O[C@H]32)[C@@H]2C=C[C@H]1C2.
What is the InChIKey of (1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane?
The InChIKey is HWMIOEAGGSYLQC-HSBSSMNMSA-N. The full InChI is InChI=1S/C20H30O6/c1-19(2)23-15-14(13-11-7-6-10(8-11)12(13)9-21-5)22-18-17(16(15)24-19)25-20(3,4)26-18/h6-7,10-18H,8-9H2,1-5H3/t10-,11+,12-,13+,14+,15-,16-,17+,18+/m0/s1.
What are the key properties of (1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane?
(1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane has a molecular weight of 366.45 g/mol, XLogP of 2.47, 3 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,2R,6R,8R,9S)-8-[(1S,2R,3S,4R)-3-(methoxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecane is sourced from PubChem (CID 100942568), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).